Allergy Delabeling in Antibiotic Stewardship - Evaluations

Not yet recruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2028

Study Completion Date

October 31, 2029

Conditions
Beta Lactam Allergy in Patients With a Hematologic Malignancy
Interventions
BEHAVIORAL

Semi-structured interview

Interviews designed to obtain information about patient reasons for enrolling or declining participation in the RENEW Intervention

BEHAVIORAL

Survey

Survey which will incorporate a series of closed-ended questions eliciting attitudes about the feasibility and acceptability of the intervention, allergy delabeling and future BL antibiotic use

BEHAVIORAL

Ethnographic observation

Observations designed to identify communication and contextual barriers to the implementation of RENEW

BEHAVIORAL

Survey

Survey instruments will measure knowledge,attitudes, and practices surrounding allergy delabeling and antibiotic stewardship in patients with HM and perceptions of the feasibility and acceptability of the RENEW intervention

BEHAVIORAL

Semi-structured interview

Interviews designed to obtain information from clinicians about their perception of the implementation of the RENEW intervention

All Listed Sponsors
collaborator

University of Utah

OTHER

lead

University of Pennsylvania

OTHER

NCT06967467 - Allergy Delabeling in Antibiotic Stewardship - Evaluations | Biotech Hunter | Biotech Hunter